Charles River Labs (CRL) PT Lowered to $464 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Charles River Labs (CRL) PT Lowered to $400 at Citi
November 4, 2021 6:45 AM EDTCiti analyst Patrick Donnelly lowered the price target on Charles River Labs (NYSE: CRL) to $400.00 (from $425.00) while maintaining a Neutral rating.... More
Charles River Labs (CRL) PT Lowered to $465 at Morgan Stanley
November 4, 2021 4:04 AM EDTMorgan Stanley analyst Ricky Goldwasser lowered the price target on Charles River Labs (NYSE: CRL) to $465.00 (from $480.00) while maintaining a Overweight rating.... More
Charles River Labs (CRL) PT Lowered to $440 at Evercore ISI
November 3, 2021 4:05 PM EDTEvercore ISI analyst Elizabeth Anderson lowered the price target on Charles River Labs (NYSE: CRL) to $440.00 (from $460.00) while maintaining a Outperform rating.... More
Charles River Laboratories (CRL) Tops Q3 EPS by 12c, Updates Guidance
November 3, 2021 7:09 AM EDTCharles River Laboratories (NYSE: CRL) reported Q3 EPS of $2.70, $0.12 better than the analyst estimate of $2.58. Revenue for the quarter came in at $895.9 million versus the consensus estimate of $908.19 million.
GUIDANCE:
Charles River Laboratories sees FY2021 EPS of $10.20-$10.30, versus the consensus of... More
